Ceftroxiv-TZ 562.5mg Injection
Marketer
Mediva Lifecare
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Ceftroxiv-TZ 562.5mg Injection
Ceftroxiv-TZ 562.5mg injectable solution is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby controlling infection spread. Administration must be solely under a physician's guidance; adhere strictly to the prescribed schedule. Complete the entire treatment regimen, even with symptom improvement; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals require physician consultation prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are crucial for optimal recovery. Your doctor might order lab tests and imaging to monitor therapeutic response.
Uses of Ceftroxiv-TZ 562.5mg Injection
Infections caused by bacteria
Major Benefits of Ceftroxiv-TZ 562.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ceftroxiv-TZ 562.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftroxiv-TZ 562.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Ceftroxiv-TZ 562.5mg Injection works:
Ceftriaxone/Tazobactam 562.5mg injection, marketed as Ceftroxiv-TZ, unites two active components to combat bacterial infection. Ceftriaxone, a broad-spectrum antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ceftroxiv-TZ 562.5mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftroxiv-TZ 562.5mg is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Ceftroxiv-TZ 562.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Ceftroxiv-TZ 562.5mg Injection may induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ceftroxiv-TZ 562.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Ceftroxiv-TZ 562.5mg Injection cautiously, potentially requiring a modified dosage. For individuals with mild to moderate liver dysfunction, dosage alteration of Ceftroxiv-TZ 562.5mg Injection is unnecessary; however, medical consultation is advised.
What if you forget to take Ceftroxiv-TZ 562.5mg Injection :
Omit a Ceftroxiv-TZ 562.5mg Injection dose? Seek your physician's advice.
Facts to Know About Ceftroxiv-TZ 562.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently